Showing results (1-10 of 26) with videos related to
Sort By:
Pageof 3
International Journal of Cell Biology|November 29, 2013
U1 snRNP-Dependent Suppression of Polyadenylation: Physiological Role and Therapeutic Opportunities in CancerLee Spraggon, Luca CartegniDrug Discovery Today. Therapeutic Strategies|January 16, 2015
Antisense Modulation of RNA Processing as a Therapeutic Approach in Cancer TherapyLee Spraggon, Luca CartegniNature Genetics|April 2, 2002
Disruption of an SF2/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1Luca Cartegni, Adrian R KrainerMethods in Molecular Biology (Clifton, N.J.)|August 3, 2017
In Vitro Modulation of Endogenous Alternative Splicing Using Splice-Switching Antisense OligonucleotidesJeong Eun Park, Luca CartegniNature Structural Biology|January 14, 2003
Correction of disease-associated exon skipping by synthetic exon-specific activatorsLuca Cartegni, Adrian R KrainerPlos One|March 9, 2013
5' UTR control of native ERG and of Tmprss2:ERG variants activity in prostate cancerFrancesca Zammarchi, George Boutsalis, Luca CartegniNature Reviews. Genetics|April 23, 2002
Listening to silence and understanding nonsense: exonic mutations that affect splicingLuca Cartegni, Shern L Chew, Adrian R KrainerAmerican Journal of Human Genetics|July 30, 2002
BRCA2 T2722R is a deleterious allele that causes exon skippingJames D Fackenthal, Luca Cartegni, Adrian R Krainer, et al.Nucleic Acids Research|June 26, 2003
ESEfinder: A web resource to identify exonic splicing enhancersLuca Cartegni, Jinhua Wang, Zhengwei Zhu, et al.American Journal of Human Genetics|December 31, 2005
Determinants of exon 7 splicing in the spinal muscular atrophy genes, SMN1 and SMN2Luca Cartegni, Michelle L Hastings, John A Calarco, et al.Pageof 3